Latest insights

Catalyst - Episode 6: The impact of European data regulation on the life sciences and healthcare industry

Catalyst Episode 6

The GDPR, Data Act, AI Act, upcoming European Health Data Space (EHDS) Regulation and developments in competition law create an increasingly complex web for businesses to navigate.

Global | Webinar | February 13, 2024
Catalyst - Episode 5: Capturing the value of trade secrets

Catalyst Episode 5

In today’s ever-evolving business landscape, the importance of a comprehensive trade secrets strategy is skyrocketing.

Global | Webinar | December 04, 2023
Catalyst - Episode 4: M&A trends in Life Sciences Healthcare

Catalyst Episode 4

Members of NRF corporate team are joined by Steffen Brand, Senior Associate at Archimed private equity company, to discuss recent and anticipated trends in the sector.

Global | Webinar | February 09, 2023
Catalyst - Episode 3: Patent strategies

Catalyst Episode 3

The recent CNMC decision against MSD, Swiss/EU raids of Novartis, and Teva EC Statement of Objections suggest that European competition regulators are again considering the types of conduct by patent holders that can cross the line to become an abuse of dominance.

Global | Webinar | December 19, 2022
Catalyst - Episode 2: Excessive Pricing

Digital catalyst episode 2

Aspen came into spotlight when it acquired oncology drugs after their patents expired in 2009. Following the Italian Competition Authority's decision to fine Aspen, the European Commission stepped in to consider its conduct elsewhere in Europe, reaching a settlement intended to provide guidance concerning the application of excessive pricing in the pharmaceutical sector.

Global | Webinar | September 08, 2022
Catalyst - Episode 1: EHDS Regulation

Catalyst Episode 1

Ever increasing demand for, and reliance on, digital health solutions have led to the creation of large amounts of health data. On May 3, 2022, the EU Commission published its proposal for a European Health Data Space Regulation (EHDS Regulation) with the goal of enabling patients to control access to their health data while also enabling researchers, innovators and policy makers to use that health data to benefit society at large.

Global | Webinar | June 30, 2022


Contact

Miranda Cole
Miranda Cole
Partner
Email
miranda.cole@nortonrosefulbright.com
T: +32 (2) 2376198

Recent publications

Court building's stone pillars viewed from below

Publication

ECJ confirms public tenders’ restrictions for companies from third countries with no procurement agreement with the EU

EU Member States may allow companies from countries that have not concluded an agreement guaranteeing equal and reciprocal access to public procurement (public procurement agreement) with the EU to participate in public tenders, provided there is no EU act excluding the relevant country.

Global | November 15, 2024

Antitrust and competition
London skyscrapers

Publication

Essential Corporate News – Week ending 15 November 2024

On 11 November 2024, the Financial Reporting Council (FRC) published a consultation document setting out proposed changes to the 2020 UK Stewardship Code (Code).

United Kingdom | November 15, 2024

Corporate, M&A and securities
a chain breaking off into flying birds

Publication

Modern Slavery

Since January 1, 2024, federal legislation in Canada requires companies of a certain size that produce, sell, distribute or import goods into Canada to file a report by May 31 each year regarding the risks of forced labour and child labour in their business and supply chains and the efforts taken to reduce those risks.

Canada | November 2024

Corporate governance
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now